Calyxo garners $32.7M for kidney stone treatment July 8, 2022 By Annette Boyle Calyxo Inc. cleaned up with a $32.7 million series C financing round to support further development of the Cvac system for kidney stones. Questa Capital and CRG led the round, which brought the company’s total funds raised to $47.2 million.Read More
Walden Biosciences enters research collaboration with University of Michigan on suPAR genetics July 6, 2022
New K(Ca) 1.1 channel activators identified at Gwangju Institute of Science and Technology May 5, 2022
RSS
